Contact Us

Dr. Scott Gottlieb on the impact of Pres. Trump’s policies on Big Pharma and R&D

Thought Leader: Scott Gottlieb
May 14, 2025
Source: CNBC

Former FDA Commissioner Dr. Scott Gottlieb joins ‘Squawk Box’ to discuss the impact of President Trump’s tariff policy and executive order on the pharmaceutical industry, impact on R&D and new drug development, and more.

 

Dr. Scott Gottlieb, former FDA Commissioner, brings deep insight into the intersection of healthcare policy and pharmaceutical innovation. With extensive experience in public health leadership, he provides expert analysis on the impacts of regulation, tariffs, and industry trends. For speaking inquiries, contact WWSG.

Relevant posts

Donald Trump and Kamala Harris Debate

David Frum: How Harris Roped a Dope

This piece is by WWSG exclusive thought leader, David Frum. Vice President Kamala Harris walked onto the ABC News debate stage with a mission: trigger…

Written by: David Frum

Thought Leader: David Frum

Subscribe to the WWSG newsletter.

Check Availability

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

0
Speaker List
Share My List